Online Medical Shop

My Cart:

0 item(s) - KWD0.00
You have no items in your shopping cart.

0

More Views

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics, 1e (The Clinics: Internal Medicine)

Author: Cush

ISBN: 9781455750658

Shipping Weight: 0.41 KG

Availability: In stock

Stock Qty: 1

KWD4.20

Quick Overview

Pages: 240,
Specialty: Rheumatology,
Publisher: Elsevier,
Publication Year: 2006,
Cover: Hardback,
Dimensions: 160.02x231.14x15.24mm

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today - drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.

Weight: 0.41 KG
OR

Details

Pages: 240,
Specialty: Rheumatology,
Publisher: Elsevier,
Publication Year: 2006,
Cover: Hardback,
Dimensions: 160.02x231.14x15.24mm

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today - drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.

Weight: 0.41 KG

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.